I volunteered for Johnson & Johnson’s vaccine trial, which wraps in January and could include a one-shot vaccine. I hope that I can look back on this moment with pride. – Sports Grind Entertainment

Lisa Bari is a health IT policy expert participating in the Johnson & Johnson ENSEMBLE 2 study for the COVID-19 vaccine. Lisa Bari

• Lisa Bari is a 39-year-old health IT policy exec based in Baltimore, Maryland who is participating in a late-stage trial of Johnson & Johnson’s experimental coronavirus vaccine.
• She received the first dose of vaccine or placebo on November 30 and is scheduled to receive the second dose on January 27.
• While Bari is in the two-dose phase of the trial, Johnson & Johnson…

Click here to view the original article.